Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Stock

Hyundai expands beyond cars with new AI robot designed for autonomous tasks

admin by admin
December 3, 2025
in Stock
0
Hyundai expands beyond cars with new AI robot designed for autonomous tasks
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Hyundai Motor Group is preparing to introduce a new artificial intelligence-powered mobility robot next year, signalling how the South Korean carmaker is widening its ambitions beyond traditional vehicles.

The Mobile Eccentric Droid, which will be the company’s first mass-produced mobility robot platform, is scheduled to enter production in the first half of the year.

The device is designed as a compact, four-wheeled base equipped with autonomous navigation and advanced sensors, allowing it to perform a range of tasks in different industries.

The launch reflects how AI and robotics are becoming central to Hyundai’s long-term mobility strategy.

Hyundai shifts deeper into robotics

The Mobile Eccentric Droid is built as a streamlined platform that can operate independently without human control.

Its navigation system and sensor stack allow it to map its environment, avoid obstacles, and carry out tasks such as deliveries or film production support.

Hyundai is positioning the robot as a flexible tool that can adapt to various professional uses, fitting into a wider trend where carmakers are exploring robotics as a new commercial path.

The company has not disclosed the robot’s price or planned output levels. It aims to reach 10,000 sales within three years, describing that goal as achievable once manufacturing picks up.

Production will begin in the first half of next year, marking Hyundai’s first large-scale entry into the mobility robot market.

Software links connect robots and vehicles

Hyundai says the platform is built with software similar to that used in its vehicles.

By developing a robot that shares the same underlying architecture as its car systems, the company expects improvements in one area to benefit the other.

This approach positions the droid as part of a broader ecosystem where advances in autonomous functions, sensor processing, and AI navigation can move between robotics and automotive engineering.

Carmakers worldwide are moving in a similar direction.

Robotics is no longer limited to manufacturing lines, and companies are exploring how automated platforms can support production, logistics, and even car experiences.

Hyundai’s move reflects this shift, with AI now central to how large automakers plan their next phase of mobility development.

Investment in AI and robotics continues to rise

Hyundai established its Robotics Lab in 2019, creating a dedicated centre for technology development.

In 2021, it expanded its footprint by acquiring Boston Dynamics, known globally for its research robots.

The company also plans to invest 125 trillion won in South Korea over the next five years, covering AI, robotics, and next-generation technologies.

The company expects AI-led systems to influence a wide range of industries, especially in manufacturing and hazardous work environments.

Hyundai has highlighted how robotics can reduce risks by taking on dangerous tasks, improving workplace safety, and efficiency.

With the Mobile Eccentric Droid set to enter production, Hyundai is preparing to integrate robotics more directly into its commercial strategy.

The platform marks a step towards combining automotive technology with autonomous systems as the company positions itself within the fast-expanding global robotics sector.

The post Hyundai expands beyond cars with new AI robot designed for autonomous tasks appeared first on Invezz


Previous Post

Amazon Trainium3 AI chip: 5 ways it threatens Nvidia

Next Post

India’s iron ore imports hit 6-year peak on domestic shortage, favorable global prices

Next Post
India’s iron ore imports hit 6-year peak on domestic shortage, favorable global prices

India’s iron ore imports hit 6-year peak on domestic shortage, favorable global prices

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

December 24, 2025
GLP-1 weight-loss pills set to reshape US food demand in 2026

GLP-1 weight-loss pills set to reshape US food demand in 2026

December 24, 2025
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

December 24, 2025
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

December 24, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    December 24, 2025
    GLP-1 weight-loss pills set to reshape US food demand in 2026

    GLP-1 weight-loss pills set to reshape US food demand in 2026

    December 24, 2025
    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    December 24, 2025
    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    December 24, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved